Phibro Animal Health Corp. - Ordinary Shares - Class A
PAHC
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.4B
Close$
$-5.08
114.7% downside
Current Fair Value
114.7% downsideOvervalued by 114.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.40 Billion |
|---|---|
| Enterprise Value | $2.13 Billion |
| Dividend Yield | $0.48 (1.39%) |
| Earnings per Share | $2.46 |
| Beta | 0.47 |
| Outstanding Shares | 40,600,000 |
Return
| Return on Equity | 25.87% |
|---|---|
| Return on Assets | 6.64% |
| Return on Invested Capital | 15.93% |
Valuation & Multiples
| P/E Ratio | 14.05 |
|---|---|
| PEG | 53.94 |
| Price to Sales | 0.93 |
| Price to Book Ratio | 3.83 |
| Enterprise Value to Revenue | 1.4 |
| Enterprise Value to EBIT | 11.28 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 2.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$0.72
Average shareholder expectationRevenue Estimate
$386.49 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.77
Average shareholder expectationRevenue Estimate
$379.38 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.7895▲ 24.63% |
|---|---|
| Total Calls | 15,200▼ 6.17% |
| Total Puts | 57,600▲ 0.35% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 52.40%▲ 2.19% |
|---|---|
| Total Invested | $668.70M▼ 40.52% |
| Investors Holding | 215▼ 47.00% |
ESG Score
No data
About Phibro Animal Health Corp.
CEO: Jack Bendheim